Former smokers who switch to vaping instead of quitting nicotine entirely face elevated lung cancer death risks, according to research involving 4.5 million people.
The study, reported in New Scientist, followed ex-smokers across a large population cohort. Researchers found that those who transitioned to e-cigarettes after leaving traditional cigarettes showed higher mortality rates from lung cancer compared to people who achieved complete cessation without vaping.
The finding challenges the common perception that vaping serves as a safe stepping stone away from smoking. While e-cigarettes contain fewer toxic chemicals than combustible cigarettes, the research suggests that maintaining nicotine addiction through vaping may undermine the protective health gains smokers gain by quitting.
The mechanism remains unclear. Researchers theorize that continued nicotine exposure, even without the carcinogens in cigarette smoke, could perpetuate lung damage or suppress immune responses that normally prevent cancer development. Alternatively, former smokers using vapes may continue inhaling harmful chemicals present in e-cigarette aerosol, including formaldehyde and acetaldehyde.
The study's scale provides statistical power but carries important limitations. Observational research cannot prove causation, and confounding variables could explain the association. Former smokers who switch to vaping might differ from those who quit completely in unmeasured ways, such as baseline health status or exposure to other risk factors.
The research arrives amid ongoing debate over e-cigarettes' public health role. Regulators and health organizations position vaping as a harm-reduction tool for active smokers unwilling to quit entirely. This study suggests that framing requires nuance. For people transitioning away from smoking, complete nicotine cessation appears preferable to vaping.
Public health officials should incorporate these findings into cessation messaging. Smokers benefit from understanding that e-cigarettes may extend rather